
|Articles|September 12, 2016
Takeda Partners With PRA Health Sciences
Takeda Pharmaceuticals has entered into a partnership agreement with PRA Health Sciences.
Advertisement
Takeda Pharmaceuticals has entered into a partnership agreement with PRA Health Sciences. Under this agreement PRA will manage Takeda’s pipeline and marketed products, clinical development and post-approval needs.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
New ICON Survey Shows Sites Face Growing Delays and Communication Gaps During Study Startup
2
Targeted and Strategy-Driven Clinical Development
3
Voyxact Lands FDA Accelerated Approval Following Positive Results in Phase III VISIONARY Trial
4
ACT Brief: FDA’s Agentic AI Rollout, Exercise Interventions for Long COVID, and Patient-Centered Evidence Beyond the Trial
5






.png)



.png)



.png)
.png)
